2024 HCPCS Code G9071
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
TAGS: adenocarcinoma invasive disease carcinoma female demonstration include predominant stage cancer evidence metastases ductal
Short Description | Onc dx brst stg1-2b hr,nopro |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2007 |
HCPCS Code Added Date | January 01, 2006 |
HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- G8879 - Node neg inv brst cncr
- G8880 - Sen lym p node biop not perf
- G8881 - Brst cncr stage > t1n0m0
- G8882 - No sent lymph node biopsy
- G8883 - Rev, comm, track, doc biopsy
- G8884 - Doc reas biopsy not review
- G8885 - No rev, comm, track biopsy
- G8886 - Bp under control
- G8887 - Doc med reas bp not control
- G8888 - Bp not under control
- G8889 - No doc bp
- G8890 - Ldl-c under control
- G8891 - Doc med reas no ldl-c contrl
- G8892 - Doc med reas no ldl-c test
- G8893 - Ldl-c not under control
- G8894 - Ldl-c not performed
- G8895 - Antrom prescribe
- G8896 - Doc med reas no antihtrom
- G8897 - Antithrom not prescribe
- G8898 - Copd measures group